
Windtree Therapeutics Cuts Preferred Stock by Over 99% Ahead of Crypto Strategy Rollout
WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) announced major reductions in its outstanding Series C and Series D preferred shares, positioning the company to limit future equity dilution as it …
Windtree Therapeutics Cuts Preferred Stock by Over 99% Ahead of Crypto Strategy Rollout Read More